Skip to content

What makes you not a candidate for methotrexate?

4 min read

Over 77% of patients starting methotrexate experience at least one adverse event in the first year, highlighting the importance of proper screening [1.11.1]. Understanding what makes you not a candidate for methotrexate is crucial for ensuring patient safety and treatment efficacy.

Quick Summary

Certain conditions make methotrexate unsafe. These include pregnancy, breastfeeding, severe liver or kidney disease, immunodeficiency, and specific blood disorders. Careful evaluation by a doctor is essential before starting treatment.

Key Points

  • Pregnancy & Breastfeeding: Methotrexate is an absolute contraindication due to high risk of fetal harm and its presence in breast milk [1.2.1, 1.2.2].

  • Liver Disease: Patients with alcoholism or chronic liver disease should not take methotrexate for non-cancer conditions due to the risk of severe liver damage [1.2.2, 1.5.2].

  • Kidney Disease: Impaired kidney function is a major concern, as it can cause toxic accumulation of the drug; it's contraindicated in severe CKD [1.4.3, 1.6.3].

  • Blood Disorders: Pre-existing blood problems like severe anemia, leukopenia, or bone marrow hypoplasia are contraindications for RA and psoriasis patients [1.2.2].

  • Immunodeficiency: Individuals with immunodeficiency syndromes should not receive methotrexate for RA or psoriasis [1.2.2].

  • Drug Interactions: Common drugs like NSAIDs (ibuprofen), PPIs (omeprazole), and alcohol can dangerously increase methotrexate toxicity [1.9.1, 1.9.2].

  • Active Infections: Methotrexate suppresses the immune system and should be avoided in patients with active infections [1.2.3, 1.4.2].

In This Article

Methotrexate is a powerful medication used to treat various conditions, from cancers like leukemia to autoimmune diseases like rheumatoid arthritis and severe psoriasis [1.2.4]. It works by interfering with the growth of rapidly dividing cells and by decreasing the activity of the immune system [1.2.4, 1.7.1]. However, its potent effects mean it is not suitable for everyone. A thorough evaluation of a patient's health status is critical to determine if they are a good candidate.

Absolute Contraindications: When Methotrexate is Strictly Avoided

Certain conditions are considered absolute contraindications, meaning the drug should not be used.

  • Pregnancy and Breastfeeding For non-neoplastic diseases, methotrexate is strictly contraindicated in pregnancy due to its potential to cause embryo-fetal toxicity, birth defects, and fetal death [1.2.1, 1.2.2]. Both male and female patients of reproductive potential must use effective contraception during treatment and for a period after the final dose (at least three months for males and for at least one ovulatory cycle for females) [1.2.2, 1.4.4]. It is also contraindicated in nursing mothers because the drug passes into breast milk, posing a risk of serious adverse reactions in the infant [1.2.2, 1.8.2].
  • Known Hypersensitivity Patients with a history of severe hypersensitivity or allergic reactions to methotrexate, including anaphylaxis, should not receive the drug [1.2.1, 1.4.1].
  • Significant Pre-existing Conditions (for RA/Psoriasis) For patients with rheumatoid arthritis or psoriasis, several other conditions are absolute contraindications:
    • Alcoholism or Chronic Liver Disease Methotrexate can cause severe liver damage (hepatotoxicity), and patients with alcoholism, alcoholic liver disease, or other chronic liver diseases are at high risk [1.2.2, 1.5.2].
    • Immunodeficiency Syndromes Patients with overt or laboratory evidence of immunodeficiency syndromes should not take methotrexate [1.2.2].
    • Pre-existing Blood Dyscrasias This includes conditions like bone marrow hypoplasia, significant anemia, leukopenia (low white blood cell count), or thrombocytopenia (low platelet count) [1.2.2].

Relative Contraindications and High-Risk Groups

Beyond absolute contraindications, several conditions require extreme caution and may make a patient a poor candidate. In these cases, a physician must weigh the potential benefits against the significant risks.

  • Kidney (Renal) Impairment Methotrexate is primarily cleared by the kidneys, so impaired renal function can lead to toxic accumulation of the drug [1.6.3]. Dose reduction is often necessary for patients with mild-to-moderate kidney disease, and the drug is generally avoided in those with severe kidney disease (creatinine clearance <30 mL/min) [1.4.3, 1.6.1, 1.6.3].
  • Liver (Hepatic) Impairment Patients with any liver condition are at higher risk for methotrexate-related adverse reactions due to altered drug elimination [1.2.1]. Long-term therapy is associated with the development of fatty liver, progressive fibrosis, and even cirrhosis [1.5.2]. Regular monitoring of liver function is essential for anyone taking the drug [1.10.1].
  • Active Infections Because methotrexate suppresses the immune system, it can increase the risk of getting an infection or worsen an existing one [1.4.2]. It is generally not recommended for people with active infections [1.2.3].
  • Gastrointestinal Issues Patients with peptic ulcer disease or ulcerative colitis should use methotrexate with extreme caution, as the drug can cause severe gastrointestinal toxicity, including stomatitis (mouth sores) and diarrhea [1.2.2].
  • Planned Vaccinations Patients should not receive "live" vaccines while using methotrexate, as this could lead to a serious infection [1.2.4].

Drug Interactions of Concern

A patient's current medication list is also a critical factor. Many drugs can interact with methotrexate, increasing the risk of toxicity:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Commonly used pain relievers like ibuprofen and naproxen can reduce the renal clearance of methotrexate, leading to elevated and potentially toxic blood levels [1.9.1, 1.9.2].
  • Proton Pump Inhibitors (PPIs) Medications like omeprazole, used for acid reflux, can also interfere with methotrexate clearance [1.9.1, 1.9.2].
  • Certain Antibiotics Penicillins and tetracyclines can reduce renal clearance or decrease intestinal absorption of methotrexate [1.2.2, 1.9.2].
  • Alcohol Consumption of alcohol should be avoided as it significantly increases the risk of methotrexate-induced liver damage [1.4.4, 1.10.3].
Contraindication Category Specific Conditions & Factors Rationale for Concern
Absolute Pregnancy, Breastfeeding, Known Hypersensitivity [1.2.1, 1.2.2] High risk of fetal death, birth defects, and severe allergic reactions [1.7.1].
Absolute (for RA/Psoriasis) Alcoholism, Chronic Liver Disease, Immunodeficiency, Blood Dyscrasias [1.2.2] Increased risk of fatal liver toxicity and severe bone marrow suppression [1.4.4, 1.5.2].
High-Risk (Relative) Kidney Disease, Active Infections, Peptic Ulcer Disease [1.2.2, 1.4.3, 1.6.2] Drug can accumulate to toxic levels or worsen underlying conditions [1.6.3].
Drug Interactions NSAIDs, PPIs, Certain Antibiotics, Alcohol [1.9.1, 1.9.2] These substances can increase methotrexate levels and/or enhance liver toxicity [1.4.4].

Conclusion: The Importance of Physician Oversight

Deciding whether a patient is a candidate for methotrexate is a complex process that requires meticulous care from a physician experienced in its use [1.4.5]. It involves a thorough review of the patient's medical history, current health status, lifestyle factors like alcohol use, and a complete list of other medications [1.10.3]. Due to the potential for severe and even fatal toxicities affecting the liver, kidneys, lungs, and bone marrow, patients must be under a doctor's care throughout therapy and adhere to a strict schedule of monitoring tests [1.2.2, 1.10.1]. These precautions are essential to mitigate the risks and ensure the safe use of this effective medication.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional before making any decisions about your health or treatment.

Explore further information on Methotrexate from the National Institutes of Health.

Frequently Asked Questions

It depends on the severity. Methotrexate is contraindicated in advanced kidney disease (creatinine clearance <30 ml/min) because it is cleared by the kidneys and can build up to toxic levels [1.6.3]. For mild-to-moderate kidney disease, a doctor may consider a reduced dose with close monitoring [1.4.3].

No, it is strongly advised to avoid alcohol while taking methotrexate. The combination significantly increases the risk of developing serious, and potentially fatal, liver damage [1.4.4, 1.10.3].

You should not take methotrexate if you are pregnant or planning to become pregnant. Both women and men should stop taking the medication for a recommended period (e.g., 3-6 months) before trying to conceive due to the risk of severe birth defects [1.4.4, 1.7.1].

Yes. For rheumatoid arthritis, absolute contraindications include pregnancy, breastfeeding, alcoholism or chronic liver disease, immunodeficiency syndromes, and pre-existing blood disorders like significant anemia or low white blood cell counts [1.2.2, 1.4.4].

You should consult your doctor before taking NSAIDs like ibuprofen. These drugs can interfere with how your body clears methotrexate, leading to increased blood levels and a higher risk of toxicity [1.9.1, 1.9.2].

Methotrexate suppresses the immune system, so it is generally not recommended for people with active infections. Taking it could make the infection more severe. Your doctor will advise you on whether to temporarily stop the medication [1.2.3, 1.4.2].

Regular blood tests are essential to monitor for serious side effects. These tests check for liver toxicity (liver function tests), bone marrow suppression (complete blood count), and kidney function, allowing doctors to catch and manage problems early [1.2.2, 1.10.1].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.